Pfizer Appoints Head of Vaccines - - BioPharm International

ADVERTISEMENT

Pfizer Appoints Head of Vaccines



Pfizer has named Albert Bourla as group president of the company’s Vaccines, Oncology and Consumer Healthcare business and Susan Silbermann as president and general manager, Global Vaccines business, both effective Jan. 1, 2014.
 
Doug Lankler, who was to become general counsel on January 1, and Rady Johnson who was to become chief compliance and risk officer on January 1, both assume their new positions immediately. 

On January 1, the company will begin operating with three commercial businesses-the Global Innovative Pharmaceutical business, led by Geno Germano, the Global Established Pharmaceutical business, led by John Young, and the Vaccines, Oncology, and Consumer Healthcare business led by Albert Bourla.

Source: Pfizer

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
USP Center in Ghana Receives International Lab Accreditation
August 15, 2014
USP Awards Analytical Research
August 15, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
Author Guidelines

Click here